Physician profile
Heidi Bailey
NPI 1700954740
$634.13
in general payments reported to CMS, 2019-2025
10 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $233 · 2022: $12.45 · 2023: $109 · 2024: $171 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $388.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $211.43 | 2021-2025 | Fasenra, Breztri |
| Glaxosmithkline, LLC. | $161.70 | 2021-2025 | Trelegy Ellipta |
| Boston Scientific Corporation | $74.36 | 2023-2024 | |
| Abbvie INC. | $47.13 | 2023-2024 | |
| Genentech USA, INC. | $40.49 | 2023-2024 | Xolair |
| Biocryst US Sales Co., LLC | $26.00 | 2025 | Orladeyo |
| Inspire Medical Systems, INC. | $23.45 | 2024 | Inspire |
| Ars Pharmaceuticals Operations, INC. | $20.05 | 2025 | Neffy |
| Regeneron Healthcare Solutions, INC. | $17.07 | 2023 | Dupixent |
| Kaleo, INC. | $12.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.